The endocrinological basis of recurrent miscarriages

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 4, 2005, Pages 424-428

  Potdar, Neelam ^a   Konje, Justin C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Endocrinology; Endometrium in recurrent miscarriage; Pprogesterone; Recurrent miscarriage

Indexed keywords

ANANDAMIDE; ANDROSTANOLONE; BIOCHEMICAL MARKER; CORTICOTROPIN RELEASING FACTOR; ENDOCANNABINOID; ESTRADIOL; ESTROGEN; FATTY ACID AMIDASE; GESTAGEN; GONADORELIN; INTERLEUKIN 6; METFORMIN; MOLECULAR MARKER; PROGESTERONE; PROLACTIN; TESTOSTERONE;

CLINICAL TRIAL; ENDOMETRIUM BIOPSY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LUTEAL INSUFFICIENCY; LUTEAL PHASE; NATURAL KILLER CELL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION;

EID: 22944457834     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000175363.20094.bd     Document Type: Review

References (46)

1. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989; 299:541-545.
2. Stirrat GM. Recurrent miscarriage. Lancet 1990; 336:673-675.
3. Habayeb OMH, Konje JC. The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome. Hum Reprod 2004; 19: 2952-2958. Findings of the paper are highly useful in the clinical setting.
4. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19:1644-1646. A comprehensive retrospective study showing the association between obesity and recurrent miscarriage: provides food for thought for further research in this area.
5. Klentzeris LD. The role of the endometrium in implantation. Hum Reprod 1997; 12(11 Suppl):170-175.
6. Wilcox AJ, Baird DD, Weinberg CR. The time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999; 340:1796-1799.
7. Serle E, Aplin JD, Li TC, et al. Endometrial differentiation in the periimplantation phase of women with recurrent miscarriage: a morphological and immunohistochemical study. Fertil Steril 1994; 62:989-996.
8. Edwards RG. Physiological and molecular aspects of human implantation. Hum Reprod 1995; 10(Suppl):1-13.
9. Lessey BA, Fritz MA. Defective luteal function. In: Fraser JS, Jansen RPS, Lobo RA, Whitehead MI, editors. Estrogens and progestogens in clinical practice. Philadelphia: W.B. Saunders; 1998. pp. 437-453.
10. Li TC. Guidelines for practitioners: Recurrent miscarriage: principles of management. Hum Reprod 1998; 13:478-482.
11. Noyes RW, Hertig AW, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
12. Saleh MI, Warren MA, Li TC, Cooke ID. A light microscopical morphometric study of the luminal epithelium of human endometrium during the periimplantation period. Human Reprod 1995; 10:1828-1832.
13. Murray MJ, Meyer WR, Zaino RJ, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril 2004; 81:1333-1343. A robust paper which is a breakthrough in evaluating the utility of histological diagnosis of luteal phase insufficiency.
14. Glueck CJ, Wang P, Fontaine RN, et al. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovarian syndrome. Metabolism 1999; 48:1589-1595.
15. Li TC, Serle E, Warren MA, Cooke ID. Is endometrial development in the peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase? Human Reprod 1993; 12:555-563.
16. Okon MA, Laird SM, Tuckerman EM, Li TC. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 1998; 69:682-690.
17. Nardo LG, Rai R, Backos M, et al. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 2002; 77:348-352.
18. Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001; 75:46-52.
19. Jakubowicz DJ, Luorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87:524-529.
20. Heard MJ, Pierce A, Carson SA, et al. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77:669-673.
21. Craig LB, Ke RW, Kutten WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002; 78:487-490.
22. Habayeb OMH, Bell SC, Konje JC. Endogenous cannabinoids: metabolism and their role in reproduction. Life Sci 2002; 70:1963-1977.
23. Maccarrone M, Valensise H, Bari M, et al. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 2000; 355:1326-1329.
24. Maccarrone M, Bisogno T, Valensise H, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 2002; 8:188-195.
25. Habayeb OMH, Taylor AH, Evans MD, et al. Plasma levels of the endocannabinoid anandamide in women: a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 2004; 89:5482-5487. Very interesting study highlighting the potential role of anandamide in implantation and the role of progestogens in regulating cannabinoids.
26. Dennedy MC, Friel AM, Houlihan DD, et al. Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol 2004; 190:2-9. Expression of endocannbinoid receptors in the pregnant myometrium has been studied and the role of endocannabinoids in the human pregnancy and parturition further explored and supported.
27. Maccarrone M, Valensise H, Bari M, et al. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol 2001; 166:7183-7189.
28. Gellersen B, Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 2003; 178:357-372.
29. Tuckerman E, Laird SM, Stewart R, et al. Markers of endometrial function in women with unexplained recurrent pregnancy loss: a comparison between morphologically normal and retarded endometrium. Hum Reprod 2004; 19:196-205. First study to relate endometrial morphology and function with the molecular markers in women with unexplained recurrent pregnancy loss.
30. Lessey BA, Killam AP, Metzger DA, et al. Immunohistochemical analysis of human uterine receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988; 67:334-340.
31. Li TC, Tuckerman EM, Laird SM. Endometrial factors in recurrent miscarriage. Hum Reprod 2002; 8:43-52.
32. Oates-Whitehead RM, Hass DM, Carrier JAK. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2004; (2). A metaanalysis of preventive use of progestogen in women with miscarriage.
33. Goldzieher JW. Double-blind trial of a progestin in habitual abortion. JAMA 1964; 188:651-654.
34. Le Vine L. Habitual abortion: a controlled clinical study of progestational therapy. West J Surg 1964; 72:30-36.
35. Swyer GIM, Daley D. Progesterone implantation in habitual abortion. BMJ 1953; 1:1073-1086.
36. + natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14:2727-2730.
37. Quenby S, Bates M, Doig T, et al. Pre-implantation endometrial leucocytes in women with recurrent miscarriage. Hum Reprod 1999; 14:2386-2391.
38. Quack KC, Vassiliadou N, Pudney J, et al. Leucocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum Reprod 2001; 16:949-955.
39. Emmer PM, Steegers EA, Kerstens HM, et al. Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod 2002; 17:1072-1080.
40. Henderson TA, Saunders PT, Moffett-King A, et al. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003; 88:440-449.
41. Aoki K, Kajiura S, Matsumoto Y, et al. Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 1995; 345:1340-1342.
42. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16:855-861.
43. Quenby S, Farquharson R, Young M, Vince G. Successful pregnancy outcome following 19 consecutive miscarriages: case report. Hum Reprod 2003; 18:2562-2564.
44. Varla-Leftherioti M, Spyropoulou-Vlachou M, Keramitsoglou T, et al. Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion. Hum Immunol 2005; 66:65-71. Novel study which further supports the role of natural killer cells and their receptors in spontaneous miscarriages. Further work in this area might suggest prophylactic and therapeutic modalities for recurrent miscarriage.
45. Malamitsi-Puchner A, Sarandakou A, Tziotis J, et al. Circulating angiogenic factors during periovulation and the luteal phase of normal menstrual cycles. Fertil Steril 2004; 81:1322-1327. A prospective study measuring angiogenic factors induced by steroid hormones during phases of the menstrual cycle, which could be correlated with their increased expression during decidualization.
46. Koga K, Osuga Y, Tsutsumi O, et al. Demonstration of angiogenin in human endometrium and its enhanced expression in the secretory phase and the decidua. J Clin Endocrinol Metab 2001; 86:5609-5614.